Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Postchemotherapy Residual Tumor Resection in patients With Elevated Tumor Markers.
The Journal of Urology ( IF 6.6 ) Pub Date : 2021-10-25 , DOI: 10.1097/ju.0000000000002270 Yue Che 1 , Carolin Buddensieck 1 , Peter Albers 1 , Achim Lusch 1 , Christian Winter 1 , Robert Große Siemer 1, 2 , Andreas Hiester 1
The Journal of Urology ( IF 6.6 ) Pub Date : 2021-10-25 , DOI: 10.1097/ju.0000000000002270 Yue Che 1 , Carolin Buddensieck 1 , Peter Albers 1 , Achim Lusch 1 , Christian Winter 1 , Robert Große Siemer 1, 2 , Andreas Hiester 1
Affiliation
The oncological benefit of postchemotherapy residual tumor resection (PC-RTR) in patients with germ cell tumors and elevated serum tumor markers (STMs) remains unclear. This analysis was performed to better define patients who benefit from surgery in this setting.
中文翻译：
肿瘤标志物升高患者的化疗后残留肿瘤切除术。
化疗后残留肿瘤切除术 (PC-RTR) 对患有生殖细胞肿瘤和血清肿瘤标志物 (STM) 升高的患者的肿瘤学益处仍不清楚。进行这项分析是为了更好地定义在这种情况下从手术中受益的患者。
更新日期：2021-10-25
中文翻译：
肿瘤标志物升高患者的化疗后残留肿瘤切除术。
化疗后残留肿瘤切除术 (PC-RTR) 对患有生殖细胞肿瘤和血清肿瘤标志物 (STM) 升高的患者的肿瘤学益处仍不清楚。进行这项分析是为了更好地定义在这种情况下从手术中受益的患者。
京公网安备 11010802027423号